DECEMBER 2017 Review now available, followed by the 2017 Annual Deal Watch Review which will be published shortly…..
Sharon is the founder and CEO of Medius Associates and has worked in business development since joining the pharma industry in 1978. Sharon therefore has more than 30 years experience in international pharmaceutical business development.
With a comprehensive knowledge of business development and licensing in the pharmaceutical industry, she has extensive experience of identifying, creating, implementing and directing international business opportunities. Sharon also has experience of negotiating and drafting a wide range of agreements with both global and national pharmaceutical companies.
As a leading authority on Partnering and Business Development, Sharon has spoken at numerous international licensing conferences and run workshops and training courses on business development. Sharon’s previous industry experience included senior business development appointments in the Wellcome Foundation Ltd [Wellcome Research and Wellcome Diagnostics]; at Medeva plc and Ono Pharmaceutical Co. Ltd. In addition to her client work, Sharon is the Editor of the Business Development & Licensing Journal published by the Pharmaceutical Licensing Group and is also the Course Director for the MSc in Pharmaceutical Business Development and Licensing run by Manchester University.
Sharon holds a BSc in Chemistry and Administration and studied for an MA in Business Law. Sharon has worked in a wide range of therapeutic fields including diabetes, oncology, respiratory, critical care, cardiovascular and diagnostics. She is the past President of the European Pharmaceutical Licensing Group Council and former Chairman of the UK Pharmaceutical Licensing Group.